What is Acadia Pharmaceuticals's accrued liabilities?

Acadia Pharmaceuticals (ACAD) reported accrued liabilities of $23.56M in Q1 2026.

How has Acadia Pharmaceuticals's accrued liabilities changed year-over-year?

Acadia Pharmaceuticals's accrued liabilities increased by 20407.8% year-over-year, from -$116K to $23.56M.

What is the long-term trend for Acadia Pharmaceuticals's accrued liabilities?

Over 2 years (2023 to 2025), Acadia Pharmaceuticals's accrued liabilities has grown at a -54.5% compound annual growth rate (CAGR), from $93.17M to -$19.27M.

Acadia Pharmaceuticals ACAD Accrued liabilities

Accrued liabilities at other companies

Jazz PharmaceuticalsJAZZ

-$7.9M-104%

BiogenBIIB

——

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's accrued liabilities?: Acadia Pharmaceuticals (ACAD) reported accrued liabilities of $23.56M in Q1 2026.
How has Acadia Pharmaceuticals's accrued liabilities changed year-over-year?: Acadia Pharmaceuticals's accrued liabilities increased by 20407.8% year-over-year, from -$116K to $23.56M.
What is the long-term trend for Acadia Pharmaceuticals's accrued liabilities?: Over 2 years (2023 to 2025), Acadia Pharmaceuticals's accrued liabilities has grown at a -54.5% compound annual growth rate (CAGR), from $93.17M to -$19.27M.